1Cell.Ai is a technology and service provider to clinical researchers in biopharma and academia.  It applies proprietary technologies to elucidate novel biological insights particularly in cancer and to improve productivity of researchers.   1Cell’s platform merges cutting-edge innovations in molecular science, single cell analysis, bioinformatics, and artificial intelligence—delivering real-time, actionable insights to clinicians, researchers, and biopharma and pharma partners worldwide.  Its leading solution called OncoIncytes is a next-generation platform integrates single-cell DNA, RNA, and protein profiling from blood to enable real-time insights into tumor biology for drug development and biomarker discovery.  Besides single cells analysis, this platform also analyzes circulating tumor DNA.  In addition, 1Cell offers iCore™ which is an advanced informatics platform built to accelerate translational research and optimize biomarker-rich clinical trials. Designed for oncology teams and research partners, the platform integrates multi-modal biological data with real-world evidence to deliver real-time, actionable insights that drive personalized cancer care.